Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Smitha Menon MD

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

Member of the Cancer Center

Publications (15)

  • Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine. (Huang H, Springborn S, Haug K, Bartow K, Samra H, Menon S, Mackinnon AC) J Mol Diagn 2019 09;21(5):862-872 PMID: 31443844 SCOPUS ID: 2-s2.0-85070830031 08/25/2019       14 Citations
  • Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series. (Le-Rademacher JG, Rowland K, Atherton PJ, Dakhil C, Sun Z, Tan A, Schmidt L, Nguyen PL, Radecki Breitkopf C, Pittelkow M, Tindall D, Menon S, Jatoi A) Am J Hosp Palliat Care 2019 Jun;36(6):519-525 PMID: 30602311 SCOPUS ID: 2-s2.0-85059568249 01/04/2019       3 Citations
  • Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC. (Lin JJ, Zhu VW, Schoenfeld AJ, Yeap BY, Saxena A, Ferris LA, Dagogo-Jack I, Farago AF, Taber A, Traynor A, Menon S, Gainor JF, Lennerz JK, Plodkowski AJ, Digumarthy SR, Ou SI, Shaw AT, Riely GJ) J Thorac Oncol 2018 10;13(10):1530-1538 PMID: 29935304 PMCID: PMC6341982 SCOPUS ID: 2-s2.0-85051033461 06/24/2018       46 Citations
  • Liquid Biopsies and Cancer Immunotherapy. (Thompson JR, Menon SP) Cancer J 2018 Mar/Apr;24(2):78-83 PMID: 29601334 SCOPUS ID: 2-s2.0-85044928489 03/31/2018       12 Citations
  • Advances in Cancer Immunotherapy in Solid Tumors. (Menon S, Shin S, Dy G) Cancers (Basel) 2016 Nov 24;8(12) PMID: 27886124 PMCID: PMC5187504 SCOPUS ID: 2-s2.0-85005959718 11/26/2016       104 Citations
  • Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options. (Desai A, Menon SP, Dy GK) Cancer Biol Med 2016 Mar;13(1):77-86 PMID: 27144064 PMCID: PMC4850130 SCOPUS ID: 2-s2.0-84969188079 05/05/2016       16 Citations
  • Should Vital Signs Be Routinely Obtained Prior to Intravenous Chemotherapy? Results From a 2-Center Study. (Menon S, Foster NR, Looker S, Sorgatz K, Kasi PM, McWilliams RR, Jatoi A) Cancer Control 2015 Oct;22(4):515-9 PMID: 26678980 SCOPUS ID: 2-s2.0-84951844462 12/19/2015    
  • Maximizing Time with the Patient: the Creative Concept of a Physician Scribe. (Menon SP) Curr Oncol Rep 2015 Dec;17(12):59 PMID: 26475774 SCOPUS ID: 2-s2.0-84945176188 10/18/2015       8 Citations
  • Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5. (Wolf SL, Qin R, Menon SP, Rowland KM Jr, Thomas S, Delaune R, Christian D, Pajon ER Jr, Satele DV, Berenberg JL, Loprinzi CL, North Central Cancer Treatment Group Study N05C5) J Clin Oncol 2010 Dec 10;28(35):5182-7 PMID: 21060036 PMCID: PMC3020691 SCOPUS ID: 2-s2.0-79951912347 11/10/2010       46 Citations
  • Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators. (Bardia A, Loprinzi C, Grothey A, Nelson G, Alberts S, Menon S, Thome S, Gill S, Sargent D) Semin Oncol 2010 Feb;37(1):39-46 PMID: 20172363 PMCID: PMC2864519 SCOPUS ID: 2-s2.0-76749168885 02/23/2010       22 Citations
  • Thromboembolic events with lenalidomide-based therapy for multiple myeloma. (Menon SP, Rajkumar SV, Lacy M, Falco P, Palumbo A) Cancer 2008 Apr 01;112(7):1522-8 PMID: 18278812 PMCID: PMC2614405 SCOPUS ID: 2-s2.0-41149161749 02/19/2008       79 Citations
  • Lenalidomide-associated hypothyroidism. (Menon S, Habermann T, Witzig T) Leuk Lymphoma 2007 Dec;48(12):2465-7 PMID: 18067027 SCOPUS ID: 2-s2.0-37149032140 12/11/2007       14 Citations
  • End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. (Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Kerr D, Green E, Wieand HS, Goldberg RM, de Gramont A, ACCENT Group) J Clin Oncol 2007 Oct 10;25(29):4569-74 PMID: 17876008 SCOPUS ID: 2-s2.0-35648964774 09/19/2007       199 Citations
  • New agents, new rashes: an update on skin complications from cancer chemotherapy. (Patiyil S, Chan SN, Jatoi A) Curr Oncol Rep 2006 Jul;8(4):269-74 PMID: 17254526 SCOPUS ID: 2-s2.0-33745647249 01/27/2007       2 Citations
  • Metastatic colorectal cancer: Therapeutic options. (Patiyil S, Alberts SR) Curr Treat Options Oncol 2006 Sep;7(5):389-98 PMID: 16904056 SCOPUS ID: 2-s2.0-33748350667 08/15/2006       7 Citations
  • Last update: 01/31/2022